We are live on ! Find out more
MC

Merck & Co Portfolio holdings

AUM $349M
1-Year Est. Return 146.07%
This Fund
S&P 500
This Quarter Est. Return
+25.93%
1 Year Est. Return
+146.07%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$276M
AUM Growth
+$48.2M
Cap. Flow
-$1.79M
Cap. Flow %
-0.65%
Top 10 Hldgs %
99.98%
Holding
13
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LVTX
LAVA Therapeutics
LVTX
+$1.79M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
1
Personalis
PSNL
$1.35B
$112M 40.47%
14,044,943
– –
MRNA icon
2
Moderna
MRNA
$21.8B
$68.1M 24.64%
2,308,190
– –
KYMR icon
3
Kymera Therapeutics
KYMR
$8.51B
$60.1M 21.75%
772,165
– –
TRDA icon
4
Entrada Therapeutics
TRDA
$264M
$17.9M 6.47%
1,739,768
– –
EVAX
5
Evaxion A/S
EVAX
$23.5M
$5.79M 2.1%
1,214,126
– –
ALEC icon
6
Alector
ALEC
$168M
$5.53M 2%
3,545,719
– –
STRO icon
7
Sutro Biopharma
STRO
$401M
$3.15M 1.14%
272,351
– –
VRDN icon
8
Viridian Therapeutics
VRDN
$2.09B
$2.91M 1.05%
93,414
– –
XLO icon
9
Xilio Therapeutics
XLO
$59.9M
$950K 0.34%
105,983
– –
CARM
10
DELISTED
Carisma Therapeutics
CARM
$63.3K 0.02%
1,473,240
– –
NEUP
11
Neuphoria Therapeutics
NEUP
$21M
$38.9K 0.01%
10,027
– –
HURA
12
TuHURA Biosciences
HURA
$138M
$10.6K ﹤0.01%
13,950
– –
LVTX
13
DELISTED
LAVA Therapeutics
LVTX
– –
-1,149,345
Closed -$1.79M

Similar funds

KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EPW
Endeavor Private Wealth Topeka, Kansas $349M AUM 16.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
FFO
Fiduciary Family Office Boca Raton, Florida $351M AUM 22.19% 1-Year Est. Return

Merck & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Merck & Co held 13 positions worth $276M, up 21% from $228M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Merck & Co's Q4 2025 filing shows 1 closed position. The largest sale was LAVA Therapeutics, an estimated $1.79M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Merck & Co fully exited LAVA Therapeutics in Q4 2025, selling an estimated $1.79M.
  • Merck & Co's ten largest holdings make up 100% of its $276M portfolio in Q4 2025.
  • Merck & Co opened 0 new positions and closed 1 in Q4 2025.
  • Merck & Co's portfolio value rose 21% quarter-over-quarter to $276M.

Based on Merck & Co's 13F filing for Q4 2025, filed 17 Feb 2026.